METABOLIC-ASSOCIATED FATTY LIVER DISEASE (MAFLD) IS ASSOCIATED WITH LOWER POST-LIVER TRANSPLANT GRAFT SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA

被引：0
|
作者：
Sierra, Leandro
Marenco-Flores, Ana
Goyes, Daniela
Barba, Romelia
Ferrigno, Bryan W.
Patwardhan, Vilas
Bonder, Alan
Saberi, Behnam
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1619
引用
收藏
页码：S1749 / S1749
页数：1
相关论文
共 50 条
  • [1] Metabolic-associated fatty liver disease (MAFLD) in coeliac disease
    Rispo, Antonio
    Imperatore, Nicola
    Guarino, Maria
    Tortora, Raffaella
    Alisi, Anna
    Cossiga, Valentina
    Testa, Anna
    Ricciolino, Simona
    Fiorentino, Andrea
    Morisco, Filomena
    LIVER INTERNATIONAL, 2021, 41 (04) : 788 - 798
  • [2] CLINICAL IMPACT OF METABOLIC-ASSOCIATED FATTY LIVER DISEASE ON LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA
    Shaikh, Anjiya
    Lymberopoulos, Peter
    Benhammou, Jihane N.
    Rich, Nicole E.
    Patel, Ankur
    Bhatnagar, Anshul
    Kim, Donghee
    Ahmed, Aijaz
    Rana, Abbas
    Lee, Tzu-Hao
    Cholankeril, George
    HEPATOLOGY, 2022, 76 : S879 - S879
  • [3] Mechanisms Linking Metabolic-Associated Fatty Liver Disease (MAFLD) to Cardiovascular Disease
    Olufunto O. Badmus
    Terry D. Hinds
    David E. Stec
    Current Hypertension Reports, 2023, 25 : 151 - 162
  • [4] Mechanisms Linking Metabolic-Associated Fatty Liver Disease (MAFLD) to Cardiovascular Disease
    Badmus, Olufunto O.
    Hinds, Terry D.
    Stec, David E.
    CURRENT HYPERTENSION REPORTS, 2023, 25 (08) : 151 - 162
  • [5] Metabolic-associated steatotic liver disease and hepatocellular carcinoma
    Catalano, Giovanni
    Chatzipanagiotou, Odysseas P.
    Kawashima, Jun
    Pawlik, Timothy M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (17) : 2283 - 2291
  • [6] Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver
    Kaya, Eda
    Yilmaz, Yusuf
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2022, 10 (02) : 329 - 338
  • [7] Metabolic-associated fatty liver disease (MAFLD) promotes the progression of hepatocellular carcinoma by enhancing KIF20A expression
    Hu, Xinsong
    Chen, Yifei
    Ying, Hao
    He, Cong
    Ren, Yangyang
    Tian, Yiqing
    Tan, Youwen
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2025, 154
  • [8] POST LIVER TRANSPLANT METABOLIC ASSOCIATED FATTY LIVER DISEASE (MAFLD). WHEN IT SHOULD RING A BELL?
    Singh, Satender Pal
    Choudhury, Ashok Kumar
    Rastogi, Archana
    Pamecha, Viniyendra
    Sarin, Shiv K.
    HEPATOLOGY, 2021, 74 : 897A - 898A
  • [9] Post-liver transplant metabolic associated fatty liver disease: Characteristics and predictive risk factors
    Gao, Jocelyn F. J.
    Gui, Hao
    Tan, Eunice X.
    Jan, Hoe
    Muthiah, Mark D.
    Pang Junxiong
    Lee, Guan-Huei
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 226 - 227
  • [10] Curcumin and Biochemical Parameters in Metabolic-Associated Fatty Liver Disease (MAFLD)-A Review
    Rozanski, Gracjan
    Kujawski, Slawomir
    Newton, Julia L.
    Zalewski, Pawel
    Slomko, Joanna
    NUTRIENTS, 2021, 13 (08)
12345